Description

This issue of Vital Signs, released on March 19, 2007, provides a strategic overview of the potential impact of regulatory changes on the total joint replacement market. Additionally, an emerging company profile is provided for NovaBone Products, a player in the synthetic bone grafting materials industry. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 5 - March 9, 2007.